CLINICAL ROLE -
Utility of the PhaSeal Closed System Drug Transfer Device
The Phaseal closed system drug transfer device provides a mechanical barrier to the entry of contaminants into sterile solutions for up to 168 hours.
Read More
Study Finds Discrepancies in Relationship Between CKD and Smoking
Navigating Prescription Stimulant Use: Safety, Legal, and Supply Challenges in Pharmacy Practice
FDA Grants Orphan Drug Designation to CNP-104 for Primary Biliary Cholangitis
FDA Grants ALG-801 Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension